Clinical Trials
183 trialsPembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
NRG Oncology
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Pembrolizumab in Treating Patients With Malignant Mesothelioma
University of Chicago
RehabKBP
University Hospital, Toulouse
A Study of Sacituzumab Govitecan in People With Mesothelioma
Memorial Sloan Kettering Cancer Center
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
COMETH
University of Kansas Medical Center
RIOT 4B
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
HIT-Meso
University College, London
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
Roswell Park Cancer Institute
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Bi-MAPS
Intergroupe Francophone de Cancerologie Thoracique
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Memorial Sloan Kettering Cancer Center
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
Short Neoadjuvant Hemithoracic IMRT for MPM
University Health Network, Toronto
From Presentation to Diagnosis: Patterns of Pleural Effusion
Mansoura University Hospital
Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
University of Chicago
IT-TCP POS
Azienda Ospedaliero-Universitaria di Parma
LAG-MAPS
Intergroupe Francophone de Cancerologie Thoracique
MesoPDT
University Hospital, Lille
DREAM3R
PrECOG, LLC.
MesoRT
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
(RIOT 4A)
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
CHIMERA
Istituto Oncologico Veneto IRCCS
......SMARTEST Trial......
University Health Network, Toronto
BIMES
Fundación GECP
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
H. Lee Moffitt Cancer Center and Research Institute
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Abramson Cancer Center at Penn Medicine
MESO-IMMUNE
Groupe Francais De Pneumo-Cancerologie
IMPALA
University Hospital, Lille
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
Memorial Sloan Kettering Cancer Center
Imaging-Meso
Istituto Oncologico Veneto IRCCS
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
National Cancer Center, China
NECIM
University Hospital, Antwerp
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
Memorial Sloan Kettering Cancer Center
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Memorial Sloan Kettering Cancer Center
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
The Cleveland Clinic
FAPI-PM
Aalborg University Hospital
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
ProgenaBiome
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
PENINSULA
Hyogo Medical University
NERO
University Hospital Southampton NHS Foundation Trust
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
Memorial Sloan Kettering Cancer Center
Olaparib in Patients With HRD Malignant Mesothelioma
University of Chicago
MESODEC
University Hospital, Antwerp
CAR T Cells in Mesothelin Expressing Cancers
University of Pennsylvania